Detalles de la búsqueda
1.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612799
2.
Real-world data for precision cancer medicine-A European perspective.
Genes Chromosomes Cancer
; 62(9): 557-563, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852573
3.
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study.
Support Care Cancer
; 30(4): 3131-3140, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34877613
4.
Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis.
BMC Pulm Med
; 22(1): 255, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35761214
5.
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.
Oncologist
; 26(6): e1058-e1065, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687742
6.
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
BMC Cancer
; 19(1): 1074, 2019 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31703637
7.
Unresectable undifferentiated sarcoma of the pulmonary artery.
Thorax
; 78(4): 423, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572535
8.
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Eur J Cancer
; 199: 113556, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271745
9.
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Eur J Cancer
; 201: 113911, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377774
10.
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.
Clin Lung Cancer
; 24(7): e282-e290, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391339
11.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Eur J Cancer
; 170: 106-118, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598358
12.
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma.
Front Oncol
; 11: 673901, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307143
13.
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report.
Case Rep Oncol
; 14(1): 477-482, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33976623
14.
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.
Front Oncol
; 11: 703893, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268127
15.
Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial.
Trials
; 21(1): 352, 2020 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321565
16.
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
Transl Lung Cancer Res
; 9(4): 1000-1014, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953480
17.
[Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment]. / Nebenwirkungsmanagement in der Immunonkologie.
Dtsch Med Wochenschr
; 144(5): 346-353, 2019 03.
Artículo
en Alemán
| MEDLINE | ID: mdl-30699440
18.
Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment.
Oncol Res Treat
; 42(12): 650-659, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634889
19.
Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
Eur J Cancer
; 205: 114130, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789333
20.
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Lung Cancer
; 119: 48-55, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656752
Resultados
1 -
20
de 20
1
Próxima >
>>